Nanoco: Maximising chances of positive litigation outcome

Nanoco has provided a further update on the litigation against Samsung for the alleged wilful infringement of the group’s IP. Nanoco has petitioned the judge in Texas to delay the court trial until after the US Patent Trial and Appeal Board (PTAB) has completed inter partes reviews (IPRs) of the five patents in the case which examine the validity of the patents themselves. At the moment the trial will be held before the IPRs.

The change in sequence improves the likelihood of a positive outcome for Nanoco but potentially extends the timescales. Nanoco’s major shareholders have indicated their intention to provide a non-dilutive debt facility of £3.0m to help support the organic activities of the group during this period.

Nanoco Group PLC (LON:NANO) leads the world in the research, development and large-scale manufacture of heavy metal-free nanomaterials for use in displays, lighting, vertical farming, solar energy and bio-imaging.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
X
LinkedIn
Nanoco Group PLC

More articles like this

Nanoco Group PLC

Quantum Dots could revolutionise your portfolio

Unlock the potential of quantum dots – microscopic particles revolutionizing industries with vibrant displays, efficient sensors, and advanced medical tools. Experience the economic opportunities with Nanoco Group PLC.

Nanoco Group PLC

QDs: Harnessing Quantum Confinement

Explore the groundbreaking research on colloidal quantum dots and their ability to control photochemical reactions through quantum coherence.

Nanoco Group PLC

The promise of Quantum Dots

Quantum dots (QDs) represent a significant advancement in nanotechnology, finding applications across diverse fields. In bioimaging, their small size enables them to access almost any part of the body, making them ideal for tasks like medical